These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1078844)

  • 1. Excitability modulation by taurine. Transmembrane measurements of neuromuscular transmission.
    Gruener R; Markovitz D; Huxtable R; Bressler R
    J Neurol Sci; 1975 Mar; 24(3):351-60. PubMed ID: 1078844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic and membrane activities of amantadine in neuromuscular transmission.
    Nastuk WL; Su P; Doubilet P
    Nature; 1976 Nov; 264(5581):76-9. PubMed ID: 187945
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of droperidol on neuromuscular transmission and muscle membrane.
    Sokoll MD; Gergis SD; Post EL; Cronnelly R; Long JP
    Eur J Pharmacol; 1974 Sep; 28(1):209-13. PubMed ID: 4372066
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of rare earths and yttrium on striated muscle and the neuromuscular junction.
    Bowen JM
    Can J Physiol Pharmacol; 1972 Jun; 50(6):603-11. PubMed ID: 4538000
    [No Abstract]   [Full Text] [Related]  

  • 5. Barbiturate-induced transmitter release at a frog neuromuscular junction.
    Thomson TD; Turkanis SA
    Br J Pharmacol; 1973 May; 48(1):48-58. PubMed ID: 4353318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of taurine in the genesis of muscular dystrophy.
    Baskin SI; Dagirmanjian R
    Nature; 1973 Oct; 245(5426):464-5. PubMed ID: 4356151
    [No Abstract]   [Full Text] [Related]  

  • 7. Sea nettle (Chrysaora quinquecirrha) toxin on electrogenic and chemosensitive properties of nerve and muscle.
    Warnick JE; Weinreich D; Burnett JW
    Toxicon; 1981; 19(3):361-71. PubMed ID: 6113697
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of acute neuromuscular weakness induced by chloroquine.
    Vartanian GA; Chinyanga HM
    Can J Physiol Pharmacol; 1972 Nov; 50(11):1099-103. PubMed ID: 4640803
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of prostaglandin E1 on frog skeletal muscle.
    Marco LA; Coceani F
    Can J Physiol Pharmacol; 1973 Sep; 51(9):627-34. PubMed ID: 4543140
    [No Abstract]   [Full Text] [Related]  

  • 10. The depolarizing effect of suxamethonium on the membrane potential of striated muscle fibres at endplate-free regions.
    Ras R; Mooij JJ
    Eur J Pharmacol; 1973 Sep; 23(3):217-22. PubMed ID: 4746739
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacology of batrachotoxin. V. A comparative study of membrane properties and the effect of batrachotoxin on sartorius muscles of the frogs Phyllobates aurotaenia and Rana pipiens.
    Albuquerque EX; Warnick JE; Sansone FM; Daly J
    J Pharmacol Exp Ther; 1973 Feb; 184(2):315-29. PubMed ID: 4540047
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end-plate currents in frog sartorius muscle.
    Kuba K; Albuquerque EX; Daly J; Barnard EA
    J Pharmacol Exp Ther; 1974 May; 189(2):499-512. PubMed ID: 4545375
    [No Abstract]   [Full Text] [Related]  

  • 13. Ketamine: myoneural activity and interaction with neuromuscular blocking agents.
    Cronnelly R; Dretchen KL; Sokoll MD; Long JP
    Eur J Pharmacol; 1973 Apr; 22(1):17-22. PubMed ID: 4267587
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of gallamine on nerve terminals and endplates.
    Sokoll MD; Dretchen KL; Gergis SD; Long JP
    Anesthesiology; 1973 Feb; 38(2):157-65. PubMed ID: 4346242
    [No Abstract]   [Full Text] [Related]  

  • 15. Excitability modulation by taurine: action on axon membrane permeabilities.
    Gruener R; Bryant HJ
    J Pharmacol Exp Ther; 1975 Sep; 194(3):514-21. PubMed ID: 1159628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine-induced depression of neuromuscular transmission.
    Chinyanga HM; Vartanian GA; Okai EA; Greenberger DV
    Eur J Pharmacol; 1972 May; 18(2):256-60. PubMed ID: 4338758
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromuscular blocking action of phenethylguanidine in frog sartorius muscle.
    Nishiyama A; Kuwabara M
    Tohoku J Exp Med; 1973 Sep; 111(1):1-14. PubMed ID: 4776733
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of lanthanum ions on function and structure of frog neuromuscular junctions.
    Heuser J; Miledi R
    Proc R Soc Lond B Biol Sci; 1971 Dec; 179(1056):247-60. PubMed ID: 4400214
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of edrophonium on end-plate currents in frog skeletal muscle.
    Goldner MM; Narahashi T
    Eur J Pharmacol; 1974 Mar; 25(3):362-71. PubMed ID: 4545304
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of guanidine on transmitter release and neuronal excitability.
    Matthews G; Wickelgren WO
    J Physiol; 1977 Mar; 266(1):69-89. PubMed ID: 192882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.